149 related articles for article (PubMed ID: 36621381)
1. HLA expression as a risk factor for metastases of cutaneous squamous-cell carcinoma in organ- transplant recipients.
de Jong E; Quint KD; El Ghalbzouri A; Verdijk RM; Goeman JJ; Heidt S; Claas FHJ; de Fijter JW; Genders RE; Vermeer MH; Bouwes Bavinck JN
Hum Immunol; 2023 Mar; 84(3):208-213. PubMed ID: 36621381
[TBL] [Abstract][Full Text] [Related]
2. Solid organ transplantation worsens the prognosis of patients with cutaneous squamous cell carcinoma of the head and neck region-Comparison between solid organ transplant recipients and immunocompetent patients.
Ritter A; Badir S; Mansour M; Segal Z; Ad-El D; Bachar G; Shpitzer T; Popovtzer A; Mizrachi A
Head Neck; 2021 Mar; 43(3):884-894. PubMed ID: 33247523
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of Patients With Multiple Cutaneous Squamous Cell Carcinomas: A 10-Year Single-Institution Cohort Study.
Levine DE; Karia PS; Schmults CD
JAMA Dermatol; 2015 Nov; 151(11):1220-5. PubMed ID: 26177278
[TBL] [Abstract][Full Text] [Related]
4. Tumor cell-specific AIM2 regulates growth and invasion of cutaneous squamous cell carcinoma.
Farshchian M; Nissinen L; Siljamäki E; Riihilä P; Piipponen M; Kivisaari A; Kallajoki M; Grénman R; Peltonen J; Peltonen S; Quint KD; Bavinck JNB; Kähäri VM
Oncotarget; 2017 Jul; 8(28):45825-45836. PubMed ID: 28526809
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous squamous cell cancer (cSCC) risk and the human leukocyte antigen (HLA) system.
Yesantharao P; Wang W; Ioannidis NM; Demehri S; Whittemore AS; Asgari MM
Hum Immunol; 2017 Apr; 78(4):327-335. PubMed ID: 28185865
[TBL] [Abstract][Full Text] [Related]
6. Metastasis of cutaneous squamous cell carcinoma in organ transplant recipients and the immunocompetent population: is there a difference? a systematic review and meta-analysis.
Genders RE; Weijns ME; Dekkers OM; Plasmeijer EI
J Eur Acad Dermatol Venereol; 2019 May; 33(5):828-841. PubMed ID: 30793804
[TBL] [Abstract][Full Text] [Related]
7. Degree of differentiation of cutaneous squamous cell carcinoma: a comparison between a Swedish cohort of organ transplant recipients and immunocompetent patients.
Stenman C; Gonzalez H; Gillstedt M; Dellgren G; Hasséus B; Holmberg E; Rexius H; Öhman J; Paoli J
Dermatol Pract Concept; 2018 Oct; 8(4):330-336. PubMed ID: 30479868
[TBL] [Abstract][Full Text] [Related]
8. Identification of genetic mutations of cutaneous squamous cell carcinoma using whole exome sequencing in non-Caucasian population.
Lee SY; Lee M; Yu DS; Lee YB
J Dermatol Sci; 2022 May; 106(2):70-77. PubMed ID: 35365379
[TBL] [Abstract][Full Text] [Related]
9. Cumulative incidence and timing of subsequent cutaneous squamous cell carcinomas stratified for patients with organ transplantation and hematologic malignancies: A nationwide cohort study.
Eggermont CJ; Hollestein LM; Hollatz A; Louwman M; Mooyaart AL; Nijsten T; Wakkee M
J Am Acad Dermatol; 2024 Mar; 90(3):530-536. PubMed ID: 37871807
[TBL] [Abstract][Full Text] [Related]
10. Cumulative incidence and risk factors for cutaneous squamous cell carcinoma metastases in organ transplant recipients: The Skin Care in Organ Transplant Patients in Europe-International Transplant Skin Cancer Collaborative metastases study, a prospective multicenter study.
de Jong E; Genders R; Harwood CA; Green AC; Plasmeijer EI; Proby C; Geissler E; Ferrándiz-Pulido C; Ducroux E; Euvrard S; Geusau A; Jahn-Bassler K; Borik-Heil L; Rácz E; Nägeli M; Hofbauer GFL; Piaserico S; Russo I; Mackintosh L; Borges-Costa J; Angeliki-Gkini M; Zavattaro E; Savoia P; Imko-Walszuk B; Dębska-Slizień A; Garmyn M; van Kelst S; Ricar J; Cetkovska P; Matin R; Güleç AT; Seçkin D; Anene CA; Oliveira WRP; Rademaker M; Goeman J; van Geloven N; Ruiz E; Murad F; Karn E; Schmults CD; Bouwes Bavinck JN
J Am Acad Dermatol; 2024 Jun; 90(6):1200-1209. PubMed ID: 38301923
[TBL] [Abstract][Full Text] [Related]
11. Risk Factors and Prognosis for Metastatic Cutaneous Squamous Cell Carcinoma: A Cohort Study.
Knuutila JS; Riihilä P; Kurki S; Nissinen L; Kähäri VM
Acta Derm Venereol; 2020 Sep; 100(16):adv00266. PubMed ID: 32930344
[TBL] [Abstract][Full Text] [Related]
12. UV-type specific alteration of miRNA expression and its association with tumor progression and metastasis in SCC cell lines.
Chen IP; Bender M; Spassova I; Henning S; Kubat L; Fan K; Degenhardt S; Mhamdi-Ghodbani M; Sriram A; Volkmer B; Boukamp P; Becker JC; Greinert R
J Cancer Res Clin Oncol; 2020 Dec; 146(12):3215-3231. PubMed ID: 32865618
[TBL] [Abstract][Full Text] [Related]
13. INK4-ARF and p53 mutations in metastatic cutaneous squamous cell carcinoma: case report and archival study on the use of Ink4a-ARF and p53 mutation analysis in identification of the corresponding primary tumor.
Blokx WA; Ruiter DJ; Verdijk MA; de Wilde PC; Willems RW; de Jong EM; Ligtenberg MJ
Am J Surg Pathol; 2005 Jan; 29(1):125-30. PubMed ID: 15613867
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Outcomes of Cutaneous Squamous Cell Carcinoma in Solid Organ Transplant Recipients: A Retrospective Comparative Cohort Study.
Salido-Vallejo R; Escribano-Castillo L; Antoñanzas J; Roldán-Córdoba C; Velez A; Aguado-Gil L
J Clin Med; 2023 Dec; 12(24):. PubMed ID: 38137687
[TBL] [Abstract][Full Text] [Related]
15. Incidence of Multiple vs First Cutaneous Squamous Cell Carcinoma on a Nationwide Scale and Estimation of Future Incidences of Cutaneous Squamous Cell Carcinoma.
Tokez S; Hollestein L; Louwman M; Nijsten T; Wakkee M
JAMA Dermatol; 2020 Dec; 156(12):1300-1306. PubMed ID: 33112377
[TBL] [Abstract][Full Text] [Related]
16. Identification of proteins associated with development of metastasis from cutaneous squamous cell carcinomas (cSCCs) via proteomic analysis of primary cSCCs.
Shapanis A; Lai C; Smith S; Coltart G; Sommerlad M; Schofield J; Parkinson E; Skipp P; Healy E
Br J Dermatol; 2021 Apr; 184(4):709-721. PubMed ID: 32794257
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous Squamous Cell Carcinomas in Solid Organ Transplant Recipients Compared With Immunocompetent Patients.
Cheng JY; Li FY; Ko CJ; Colegio OR
JAMA Dermatol; 2018 Jan; 154(1):60-66. PubMed ID: 29167858
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast growth factor receptor promotes progression of cutaneous squamous cell carcinoma.
Khandelwal AR; Kent B; Hillary S; Alam MM; Ma X; Gu X; DiGiovanni J; Nathan CO
Mol Carcinog; 2019 Oct; 58(10):1715-1725. PubMed ID: 31254372
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous Squamous Cell Carcinoma Outcomes in Solid Organ Transplant Recipients: A Matched Retrospective Cohort Study.
Walker TD; Liao YT; Nikahd M; Hyer M; Shahwan KT; Carr DR
Dermatol Surg; 2024 May; 50(5):412-417. PubMed ID: 38382077
[TBL] [Abstract][Full Text] [Related]
20. Poorly differentiated cutaneous squamous cell carcinomas have high incomplete excision rates with UK minimum recommended pre-determined surgical margins.
Kiely J; Kostusiak M; Bloom O; Roshan A
J Plast Reconstr Aesthet Surg; 2020 Jan; 73(1):43-52. PubMed ID: 31473117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
